STAT3 and neoplasm: Oral DHA inhibits the development of CAC by inhibiting macrophage-related inflammatory response in the early stage, including reducing the expression of cytokines, down-regulating the phosphorylation of ERK, STAT3 and NF- kB p65, and inhibiting the growth of tumor cells in the late stage (Qin et al., 2021).